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The soft coralSarcophyton glaucumis a rich resource of several bioactive cembranoids. Sarcophytol A (1) and sarcophine
(2) are cembranoid diterpenes reported from this soft coral and extensively investigated for their cancer chemopreventive
properties. This study aimed at investigating the antimetastatic potential of the major cembranoids, sarcophine (2) and
2-epi-16-deoxysarcophine (3), from the Red Sea soft coralS. glaucum. Biocatalytic transformation of3 usingRhizopus
stoloniferATCC 6227a andAbsidia spinosaATCC 6648 afforded four new metabolites,5-7 and9, along with the
known 9R-hydroxysarcophine (8). Sarcophine, 2-epi-16-deoxysarcophine, and metabolites5-9 revealed significant
antimetastatic activity against the highly metastatic mouse melanoma cell line (B16B15b). Cembranoids demonstrate a
great potential for further development as antimetastatic agents.
Soft corals are marine invertebrates possessing a vast range of
terpenoid metabolites.1 These terpenes, mainly cembranoids, rep-
resent the animal’s main chemical defense tools against its natural
predators.2,3 Cembranoids exhibit a wide range of biological
activities including neuroprotective, antimicrobial, and antitumor
properties.2,3 The soft coralSarcophytonis one of the most abundant
coral reef animals with a high cembranoid content.4 The cancer
chemopreventive properties of the two majorSarcophytoncem-
branoids, sarcophytol A (1) and sarcophine (2), are well docu-
mented.5-8 Several attempts to optimize the anticancer potential
of sarcophine have previously been reported.6-8 However, no similar
studies were reported for other major cembranoids from this soft
coral. Biocatalysis demonstrates many advantages including high
regio-, stereo-, and chemoselectivity and the ability to generate novel
and diverse derivatives.9 Biocatalysis was successfully used to
enhance the anticancer potential of sarcophine.6 The related
olibanum cembranoid incensole (4) was patented for its antiangio-
genic activity.10 Based on correlations between angiogenesis and
cancer metastasis as well as the reported chemopreventive activities
of sarcophytol A and sarcophine, cembranoids could possess
antimetastatic properties.
Hence, this study aims at (1) isolation of major cembranoids
from Sarcophyton glaucum; (2) optimization of the major cembra-
noid 2-epi-16-deoxysarcophine (3) using biocatalysis to generate
structurally diverse analogues; and (3) evaluating the ability of
cembranoids to inhibit the migration of the highly metastatic
melanoma cells (B16B15b).
Results and Discussion
Reinvestigation of the Red Sea soft coralS. glaucumled to the
isolation of two known cembranoids, sarcophine (2) and 2-epi-16-
deoxysarcophine (3), in high yields. The identification of2 and3
was based on extensive analysis of their NMR data and comparison
with the literature.11-13 There have been discrepancies in the
nomenclature of 2S,7S,8S-16-deoxysarcophine and 2R,7S,8S-16-
deoxysarcophine. Irrespective of the C-2 configuration, this com-
pound has been referred to as sarcophytoxide, 16-deoxosarcophine,
and 16-deoxysarcophine.13-15 The name 16-deoxysarcophine should
be used to describe 2S,7S,8S-16-deoxysarcophine in order to unify
the literature nomenclature and to correlate its structure with
sarcophine (2), whose absolute configuration is well established
as 2S,7S,8S by X-ray crystallography and modified Mosher’s
method.11,16 2R,7S,8S-16-Deoxysarcophine (3) should then be
named 2-epi-16-deoxysarcophine, to clearly denote the opposite
C-2 configuration compared to sarcophine.
The success of the previous bioconversion study of sarcophine
that led to metabolites with enhanced anticancer activity encouraged
a similar study for3.6 Thirty growing cultures were screened for
their ability to bioconvert 2-epi-16-deoxysarcophine. Of these,
Rhizopus stoloniferATCC 6227a andAbsidia spinosaATCC 6648
were selected for the scale-up fermentation based on the diversity
of the generated metabolites.
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Fourteen-day fermentation of3 with R. stoloniferafforded four
more polar metabolites,5-8. The HRMS data of compound5
suggested a molecular formula of C20H30O3 and six degrees of
unsaturation. The1H and13C NMR data (Table 1) suggested 1,15-
epoxidation and the presence of two macrocyclic double bonds.
The quaternary oxygenated carbons atδ 72.4 and 67.8 were
assigned to C-1 and C-15, respectively. This was aided by their
3J- and2J-HMBC correlations with the H3-17 methyl singlet. The
upfield shift of H3-17 (δ 1.45), compared with H3-17 in the parent
compound3, indicated the replacement of∆1,15 in 3 with an epoxy
functionality in 5. This was further confirmed by the2J- and 3J-
HMBC correlations of the H-2 doublet (δ 4.82) with C-1 and C-15,
respectively. The 14-membered macrocycle of3 is identical to that
of sarcophine (2), which has restricted mobility on the basis of
X-ray crystallography.11 The unique nature of sarcophine’s 14-
membered ring macrocycle was previously reported.11 The existence
of the segment C-7C-11 in a half-chair conformer, as proved by
X-ray crystallography and NOE difference data, restricts the
mobility freedom in the entire macrocycle.6,11 This was further
supported by the highJ and dihedral angle values between H-2
and H-3 in sarcophine (10.5 Hz and∼160°) and the paramagnetic
deshielding of the C-18 methyl functionality by the C-2 oxygen.6,11
This is true whenever the epoxy group is intact; hence, the relative
stereochemistry of the biocatalytic products of3 was assigned on
the basis of NOESY correlations. The presence of the C-7/C-8
epoxide forces the functional groups on C-7 and C-8 to be eclipsed
and the methylene groups C-6 and C-9 to be in an anti-configuration
around the C-7-C-8 bond.6,11 NOESY is widely employed for the
assignment of relative stereochemistry of structurally diverse
cembrane diterpenes isolated from soft corals.17,18 The R-oriented
H3-19 methyl singlet (δ 1.20) in 5 showed a strong NOESY
correlation with H3-17, indicating a similar stereo-orientation. Thus,
the C-1-C-15 epoxide group of5 should beâ-oriented.
The HRMS and NMR data of6 (Table 1) suggested a mono-
hydroxylated analogue of3. The newly oxygenated doublet of
doublets (δ 2.98,J ) 11.7 and 4.7 Hz) was assigned to H-9. The
location of the new C-9 hydroxy group was based on HMBC data.
The methyl singlet at H3-19 showed a3J-HMBC correlation with
the new oxygenated methine atδ 78.8, which was then assigned
to C-9. This assignment was also confirmed by the3J-HMBC
correlations of H-7 (δ 2.68) with C-9. The stereochemistry
assignment of C-9 was based on comparison of the13C NMR
chemical shift and coupling constants with those of the previously
reported 9R-hydroxysarcophine.6 The reported chemical shift value
of C-9 in 9R-hydroxysarcophine is atδ 78.6 and H-9 resonates at
δ 2.95 (dd,J ) 11.8, 4.1 Hz).6 By contrast, the reported C-9
chemical shift value in 9â-hydroxysarcophine is atδ 70.7 and H-9
resonates atδ 3.92 (dd,J ) 4.8, 2.1 Hz).6
The HRMS and NMR data of7 (Table 1) indicated monohy-
droxylation. The olefinic proton doublet at H-11 (δ 5.18) showed
a COSY correlation with the new oxygenated proton multiplet at
H-10 (δ 4.50). Proton H-11 also showed a2J-HMBC correlation
with C-10 (δ 65.0). TheR-orientation of H-10 was based on its
NOESY correlation with theR-oriented H3-19 (δ 1.38).
The HRMS and NMR data (Table 2) of8 suggested the
molecular formula C20H28O4, monohydroxylation, and anR,â-
unsaturated lactone system. The most downfield carbon signals at
δ 174.9 (C-16) and 162.5 (C-1) and the downfield shifted H-2 at
δ 5.44 (dq,J ) 9.7, 1.8) indicated a sarcophine-likeR,â-unsaturated
lactone. The hydroxylated proton at H-9 (δ 2.96, dd,J ) 11.7,
4.7) showed a close resemblance to that of 9R-hydroxy-2-epi-16-
deoxysarcophine (6). Compound8 was identical to the previously
reported sarcophine bioconversion product 9R-hydroxysarcophine.6
Comparison of the TLC and1H NMR of the total fermentation
mixture of 3 with R. stoloniferversus substrate control, 2-epi-16-
deoxysarcophine in blank compound mediumR, indicated that8
is a true microbial metabolite and not an artifact formed by air
oxidation of3 to sarcophine. Faulkner and co-workers previously
suggested a possible C-2 epimerization after oxidation of C-16.14
The present data provide a strong support of this prediction.
Bioconversion of3 usingA. spinosaATCC 6648 predominantly
yielded compound9. The HRMS and NMR data (Table 2) of9
suggested a monhydroxylated analogue. The oxygenated proton
multiplet at H-14 (δ 4.69) showed a COSY correlation with the
methylene protons at H2-13 (δ 2.45). The oxygenated proton
multiplet at H-2 (δ 5.70) showed a3J-HMBC correlation with C-14
(δ 66.2), confirming the hydroxylation at this position. The
R-oriented H-2 showed a NOESY correlation with H-16a (δ 4.60),
which in turn showed a NOESY correlation with H-14, suggesting
a similarR-orientation.
Antimigratory Activity. Migration and proliferation are events
underlying cancer metastasis. The antimigratory potential of three
different concentrations of compounds2-9 was evaluated using
wound-healing assays.19-21 The highly metastatic mouse melanoma
cell line (B16B15b) was used.19-21 All cembranoids showed a dose-
dependent increase in the inhibition of migration (Figures 1 and
2). Sarcophine (2) was the most potent of all tested compounds.
The 9R-hydroxy derivative (6) showed an improved activity
Table 1. 13C and1H NMR Data of Compounds5-7a
5a 6a 7a
position δC δH δC δH δC δH
1 72.4, C 133.6, C 133.5, C
2 78.2, CH 4.82, d (10.9) 85.3, CH 5.40, m 85.3, CH 5.37, m
3 122.5, CH 5.27, d (9.8) 125.5, CH 5.29, d (9.5) 124.9, CH 5.17, d (9.6)
4 142.5, C 140.2, C 139.8, C
5 35.5, CH2 2.34, m, 2.23, m 34.7, CH2 2.30, m, 2.25, m 35.0, CH2 2.29, m, 2.24, m
6 29.5, CH2 1.87, m, 1.66, m 27.0, CH2 1.87, m, 1.71, m 26.4, CH2 2.10, m, 1.77, m
7 62.4, CH 2.67, t (5.5) 62.1, CH 2.68, t (5.5) 61.6, CH 2.68, t (5.7)
8 60.0, C 63.4, C 59.4, C
9 38.5, CH 1.62, m, 1.23, m 78.8, CH 2.98, dd (11.7, 4.7) 45.4, CH2 2.22, m, 1.50, m
10 23.2, CH2 2.20, m, 2.08, m 31.5, CH2 2.45, m, 2.05, m 65.0, CH 4.50, m
11 123.0, CH 5.08, t (7.0) 118.2, CH 4.88, t (9.2) 127.0, CH 5.18, d (7.3)
12 135.2, C 138.9, C 138.5, C
13 34.5, CH2 1.95, m, 1.89, m 39.2, CH2 2.38, m, 2.35, m 38.4, CH2 2.10, m, 1.60, m
14 25.9, CH2 1.60, m 28.9, CH2 1.90, m, 1.52, m 23.0, CH2 2.40, m, 2.30, m
15 67.8, C 128.2, C 128.5, C
16 70.1, CH2 3.86, d (9.9), 3.75, d (9.9) 78.5, CH2 4.50, dq (12.0, 5.5), 4.47, dq (12.0, 5.5) 78.5, CH2 4.45, m, 4.41, m
17 12.8, CH3 1.45, 3H, s 10.5, CH3 1.65, 3H, brs 10.6, CH3 1.67, 3H, brs
18 18.6, CH3 1.90, 3H, s 17.8, CH3 1.85, 3H, s 17.6, CH3 1.78, 3H, s
19 16.4, CH3 1.20, 3H, s 10.0, CH3 1.26, 3H, s 19.5, CH3 1.38, 3H, s
20 15.7, CH3 1.62, 3H, s 15.5, CH3 1.62, 3H, s 16.2, CH3 1.62, 3H, s
a In CDCl3, 400 MHz for 1H and13C NMR. Coupling constants (J) are in Hz.
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compared to its parent compound 2-epi 16-deoxysarcophine (3).
Cembranoids (1 and 10µM) did not show a significant effect on
cell proliferation, indicating that cembranoids’ tumor cell migration
inhibition was not attributed to cytotoxicity but due to the inhibition
of migratory pathways.
Conclusions.Biocatalysis of 2-epi-16-deoxysarcophine afforded
four new and one known metabolites. The transformation of3 to
9R-hydroxysarcophine provided evidence for Faulkner’s previously
proposed hypothesis of possible C-2 epimerization after C-16
oxidation of deoxysarcophine. The antimigratory effect of cem-
branoids is reported for the first time. C-16-oxygenated cembranoids
show better antimigratory activity compared to 16-deoxycembra-
noids.
Experimental Section
General Experimental Procedures.Optical rotations were mea-
sured on a Rudolph Research Analytical Autopol III polarimeter. IR
spectra were recorded on a Nicolet Impact 400D FTIR spectropho-
tometer. The1H and13C NMR spectra were recorded in CDCl3, on a
JEOL Eclipse NMR spectrometer operating at 400 MHz for proton
and 100 MHz for carbon. The HRESITOF experiments were conducted
at the University of Michigan on a Micromass LCT spectrometer and
the University of Minnesota on a Bruker BioTOF II spectrometer. TLC
analyses were carried out on precoated silica gel G254 500 µm, using
the developing systemsn-hexane/EtOAc (3:2) and CHCl3/MeOH (4:
1). For medium-pressure liquid column chromatography (MPLC), Si
gel <63 µm particle size mesh was used.
Materials. The soft coralS. glaucumwas collected by scuba in June
2003 from Hurghada, at the Egyptian Red Sea coast. A voucher
specimen (03RS24) was deposited in the Department of Basic
Pharmaceutical Sciences, College of Pharmacy, University of Louisiana
at Monroe. The frozen soft coral (680 g) was extracted four times with
2-propanol in a percolator at room temperature. The extract (86 g) was
then concentrated under vacuum and chromatographed on silica gel
using n-hexane/EtOAc to yield 1.5 g of sarcophine (2), which was
further recrystallized from EtOAc. Further chromatographic separation
of the extract afforded the less polar 2-epi-16-deoxysarcophine (3, 4.1
g, Rf 0.50n-hexane/EtOAc, 7:3).
Biocatalysis of 2-epi-16-Deoxysarcophine.Biocatalysis studies were
conducted as described elsewhere.6 Thirty growing ATCC microbial
cultures were used for screening of3. These organisms were similar
to those previously reported in addition toAbsidia spinosaATCC 6648,
Cunninghamella homothallicaATCC 16161,CunninghamellaVerti-
cillata ATCC 8986,KluyVeromyces africanusATCC 22294,Lipomyces
starkeyiATCC 58680,Phanerochaete chrysosporiumATCC 24725,
Rhizopus niVeusATCC 200757,Rhizopus oligosporusATCC 76011,
Saccharomyces pastorianusATCC 2366, andStreptomyces malaysien-
esisBAA-13.6
R. stoloniferATCC 6227a andA. spinosaATCC 6648 were selected
for scale-up. Each of these organisms was inoculated in 10 1 L flasks
containing compound mediumR.6 After 72 h, 500 mg of3 was
dissolved in 3 mL of ethanol and evenly distributed in all flasks (250
mg per organism, 25 mg/flask). After 14 days, the growth medium
was filtered and extracted with EtOAc (4× 1000 mL). The EtOAc
layer was then concentrated under vaccuum to give 350 and 415 g of
crude extracts, respectively. Fermentation extract ofA. spinosawas
subjected to silica gel 60 column chromatography to yield 15 mg of
metabolite9 (Rf 0.25,n-hexane/EtOAc, 3:2).R. stoloniferfermentation
extract was subjected to normal-phase MPLC to collect fractions rich
in metabolites5-8. The least polar fraction was subjected to preparative
TLC on silica gel to afford compound5 (5 mg,Rf 0.28, CHCl3/MeOH,
3:2). Subsequent MPLC of other fractions afforded metabolites6 (7
Table 2. 13C and1H NMR Data of Compounds8 and9a
8a 9a
position δC δH δC δH
1 162.5, C 137.1, C
2 79.7, CH 5.44, dq (9.7, 1.8) 84.1, CH 5.70, m
3 119.3, CH 5.04, d (9.7) 125.9, CH 5.29, d (9.5)
4 145.3, C 138.5, C
5 34.6, CH2 2.41, m, 2.37, m 37.4, CH2 2.35, m, 2.28, m
6 26.6, CH2 1.80, m, 1.62, m 25.6, CH2 1.75, m, 1.65, m
7 61.2, CH 2.63, t (5.5) 61.0, CH 2.63, t (5.5)
8 63.4, C 60.8, C
9 78.6, CH 2.96, dd (11.7, 4.7) 35.9, CH2 2.08, m, 1.95, m
10 31.5, CH2 2.48, m, 2.08, m 23.4, CH2 1.54, 2H, m
11 119.2, CH 4.96, dd (10.3, 6.6) 128.0, CH 5.15, t (7.0)
12 137.6, C 128.3, C
13 37.6, CH2 2.30, m, 1.82, m 45.8, CH2 2.45, 2H, m
14 28.9, CH2 2.84, m, 1.95, m 66.2, CH 4.69, m
15 123.2, C 130.9, C
16 174.9, C 78.5, CH2 4.60, dq (12.1, 5.5), 4.42, d (12.1)
17 9.1, CH3 1.84, 3H, brs 10.7, CH3 1.64, 3H, s
18 18.3, CH3 1.93, 3H, s 15.9, CH3 1.78, 3H, s
19 9.7, CH3 1.29, 3H, s 18.1, CH3 1.23, 3H, s
20 16.9, CH3 1.64, 3H, s 16.8, CH3 1.66, 3H, s
a In CDCl3, 400 MHz for 1H and13C NMR. Coupling constants (J) are in Hz.
Figure 1. Relative gap closure in the presence of 10µM
9R-hydroxy-2-epi-16-deoxysarcophine (6) at 0 and 16 h after
wounding of B16B15b mouse melanoma cells.
Figure 2. Effect of different concentrations of sarcophine, 2-epi
16-deoxysarcophine, and cembranoid derivatives on the migration
of highly metastatic B16B15b mouse melanoma cells.
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mg,Rf 0.22, CHCl3/MeOH, 3:2),7 (9 mg,Rf 0.21, CHCl3/MeOH, 3:2),
and8 (3 mg,Rf 0.18, CHCl3/MeOH, 3:2).
Wound-Healing Assays.Murine melanoma cells (B16B15b) were
maintained in DMEM F12+ 5% FBS. The method used to detect
migration by wound-healing assay was previously described.19-21
Briefly, the cells were allowed to grow to 100% confluency in 24-well
plates. Once the monolayer developed, a wound was made with a 100
µL pipet tip. The detached cells were then washed three times with
serum-free medium (SFM). The cells were treated with 1, 10, or 100
µM solutions of each of the tested cembranoids in Dulbecco’s modified
Eagle’s medium (DMEM/F12)+ 5% FBS+ penicillin/streptomycin
(1%) for a period of 16 h. Wound width was measured immediately
before (W0) and after the 16 h (W16) incubation (∆W ) W0 - W16)
(Figure 1). Figure 2 represents wound closure values for different
concentrations of compounds (2, 3, 5-9) in millimeters, relative to
the control (time 0). All experiments were conducted independently in
triplicate.
Cell Proliferation Assays by Fluorescence-Based Analysis.B16B15b
cells were maintained as mentioned above and were plated in 24-well
tissue culture plates at 2500 cells/well. This was followed by an
incubation period of 24 h at 37°C to allow for cell attachment. On the
day of the treatment, medium was replaced with fresh growth medium
containing 1, 10, or 100µM cembranoid derivatives+ 1% penicillin
and streptomycin. Cells were then incubated for 24 h, after which the
medium was replaced with fresh growth medium containing 10%
Alamar Blue (BioSource International, Camarillo, CA). This safe,
nontoxic dye is used to monitor and assess the innate metabolic activity
of the cells.22 Cells were then incubated for 4 h, and fluorescence was
detected using a CytoFluor multiwell-plate reader (CytoFluor 4000,
Applied Biosystems, Foster City, CA).22 Cell numbers were calculated
using a standard curve. All experiments were conducted independently
and in triplicate.
Analytical Data. 1,15â-Epoxy-2-epi-16-deoxysarcophine (5):col-
orless oil; [R]D25 -10.2 (c 0.22, MeOH); UVλmax (log ε) (MeOH) 204
(3.7); IR νmax (neat) 3017, 2931, 2857, 1662, 1516, 1449, 1385, 1215,
1033, 755 cm-1; 1H and 13C NMR, see Table 1; HRESITOFm/z
341.2093 (M+ Na)+ (calcd for C20H30O3Na, 341.2093).
9r-Hydroxy-2-epi-16-deoxysarcophine (6):colorless oil; [R]D25
+52.0 (c 0.05, MeOH); UVλmax (log ε) (MeOH) 204 (4.4); IRνmax
(neat) 3018, 2930, 2858, 2399, 1521, 1436, 1215, 1032, 771, 669 cm-1;
1H and13C NMR, see Table 1; HRESITOFm/z 341.2089 (M+ Na)+
(calcd for C20H30O3Na, 341.2093).
10â-Hydroxy-2-epi-16-deoxysarcophine (7):colorless oil; [R]D25
-62.1 (c 0.19, MeOH); UVλmax (log ε) (MeOH) 204 (4.7); IRνmax
(neat) 3683, 3019, 2929, 2857, 2400, 1521, 1425, 1385, 1215, 1032,
929, 755, 669 cm-1; 1H and 13C NMR, see Table 1; HRESITOFm/z
341.2090 (M+ Na)+ (calcd for C20H30O3Na, 341.2093).
14â-Hydroxy-2-epi-16-deoxysarcophine (9):colorless oil; [R]D25
+69.3 (c 0.08, MeOH); UVλmax (log ε) (MeOH) 204 (4.2); IRνmax
(neat) 3019, 2935, 2865, 2399, 1535, 1433, 1394, 1215, 928, 759, 669
cm-1; 1H and13C NMR, see Table 2; HRESITOFm/z 341.2079 (M+
Na)+ (calcd for C20H30O3Na, 341.2093).
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